#USA #Englewood #CIRCA Scientific #Jack Darby #cardiovascular access

CIRCA Scientific Welcomes Jack Darby as Chief Executive Officer

CIRCA Scientific, Inc., a leader in cardiovascular medical devices, has recently appointed Jack Darby as its new Chief Executive Officer (CEO). This strategic move aims to propel the company into a new era of commercial growth, highlighting its commitment to pioneering access technologies in electrophysiology and structural heart procedures.

Darby's extensive background in the cardiovascular medical device sector, spanning over three decades, positions him uniquely for this role. He succeeds Lee Geist, who transitions to the Chief Operating Officer while continuing to serve on CIRCA’s Board of Directors. With the FDA’s recent clearance of innovative products like the CrossWise™ RF Transseptal Access System and the PeriCross™ Epicardial Access Kit, CIRCA is set to enhance its already recognized capabilities in esophageal temperature monitoring and expand its differentiated portfolio.

The company is eager to increase physician adoption of these novel technologies, which target critical elements in complex procedures. As more commercial-stage technologies become available, Darby’s leadership is anticipated to ensure the successful introduction of new solutions that prioritize patient care improvement and procedural efficiency.

In his remarks, Darby emphasized CIRCA's commitment to addressing significant access challenges in cardiac interventions. He illuminated the company's potential to transform current innovations into everyday resources for physicians, insisting on a client-centric approach that heavily involves collaboration with healthcare leaders.

Previously, Darby held senior roles at influential companies including Medtronic, where he served as Vice President of Cardiovascular Commercial Office. His transformative leadership and success in cultivating high-performing teams are well-documented. With a strong military background as a former Captain in the U.S. Marine Corps and an education from the University of Michigan, Darby’s prowess extends beyond industry expertise; he embodies resilience and visionary thinking.

Doug Wall, Chairman of CIRCA’s Board of Directors, expressed confidence in Darby's ability to guide the company through its next phase of expansion. His operational proficiency, alongside his cardiovascular expertise, is seen as vital for scaling the company’s market presence and fortifying its promises to patients and stakeholders.

Complementing Darby’s appointment, Geist affirmed his enthusiasm for working alongside him in the quest for commercialization and innovation. His leadership in establishing CIRCA as a recognized innovation hub lays a solid foundation for continued future success.

About CIRCA Scientific
CIRCA Scientific is at the forefront of cardiovascular medical device innovation. The company focuses on developing advanced technologies that enhance access and safety during electrophysiology and structural heart interventions. Adopting a CardioCentric™ philosophy, CIRCA collaborates with medical professionals to create solutions aimed at simplifying complex procedures and improving outcomes for patients. For more details on their transformative work, visit www.circascientific.com.

In conclusion, as Jack Darby steps into his new role, expectations are high. His experience and vision present a promising outlook for CIRCA Scientific as it continues to innovate and evolve within the healthcare landscape.